USSTOCK.TODAY
Weekend. Closed
Log in Sign up

Recursion Pharmaceuticals posts Q2 loss of $131 million, missing estimates

Associated Press +1 ·

RXRX
RXRX Recursion Pharmaceuticals Inc
$3.46 -16.71%
View chart & analysis →
NVDA -1.43%XENE XENE -2.45%XFOR XFOR -1.89%CRBP CRBP +4.39%
  1. 1Recursion Pharmaceuticals (RXRX) reported a loss of $131 million in the second quarter
  2. 2Loss per share was 25 cents, with quarterly revenue of $7.7 million
  3. 3Both figures fell short of the expected loss of 23 cents per share and revenue estimate of $14.4 million

Source Associated Press +1 · View original ↗

Related 3-line summaries

NNN REIT Q2 FFO Per Share 90 Cents, Beats Estimates Associated Press +1 · Aug 5United Therapeutics Posts Q2 Net Income of $333 Million Associated Press +1 · Aug 5Pfizer Falls ~0.5% in Early Trading Despite Strong Results and $2.5B in Savings GuruFocus.com +2 · Aug 5
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news